Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06101251 · ClinicalTrials.gov registry record · NA
A Randomized Field Trial of Smartphone-based Feedback to Encourage Safe Driving
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 1,449
- Enrollment target
NCT06101251: Completed NA study, sponsored by University of Pennsylvania.
NCT06101251 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 1,449 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06101251, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,449 participants
- Enrollment target
Study Summary
The study team are proposing to conduct a randomized controlled trial to determine the effectiveness of focused feedback vs standard feedback and self-chosen vs assigned goals on driving behaviors targeted by behavior-based insurance apps: hard braking, fast acceleration, handheld phone use, and speeding. The interventions arms will receive feedback on their driving behaviors, tips for safe driving, and a UBI-like financial incentive. The Penn research team will use Meta advertisements to recruit for the study and determine eligibility via an online survey. Those who enroll will undergo a 6-week run-in period during which their driving trips will be monitored by a mobile app. Individuals with a sufficient number of trips during this period will be randomly assigned to one of four arms for the intervention period. Target enrollment is 1,300 participants (325 per trial arm). The power analysis assumed an attrition rate of 20% over the course of the study.
Primary Outcome
This is the mean of the four behavior scores for the intervention period (and, in a follow-up analysis of effect sustainability, the post-intervention period). Scores can range from 0 -100, 100 being the safest driving score.
Interventions
- BEHAVIORAL Driving Tips
- BEHAVIORAL Standard Feedback
- BEHAVIORAL Assigned Focus Area Feedback
- BEHAVIORAL Study Dashboard (Standard)
- BEHAVIORAL Study Dashboard (focused)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,449 participants |
| Start Date | 2024-01-25 |
| Est. Completion | 2024-09-30 |
| Phase | NA |
What the finished NCT06101251 record still lists
NCT06101251 is an interventional study that assigns participants to a tested intervention. Its 1,449 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 5 interventions - of which Driving Tips is the first listed.
NCT06101251 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06101251 about?
NCT06101251 is a clinical study titled "A Randomized Field Trial of Smartphone-based Feedback to Encourage Safe Driving". The study team are proposing to conduct a randomized controlled trial to determine the effectiveness of focused feedback vs standard feedback and self-chosen vs assigned goals on driving behaviors targeted by behavior-based insurance apps: hard braking, fast acceleration, handheld phone use, and spe...
What is the current status of trial NCT06101251?
This trial is currently completed. It is a NA study. The enrollment target is 1,449 participants. The study started on 2024-01-25. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT06101251?
The interventions under investigation include: Driving Tips (BEHAVIORAL), Standard Feedback (BEHAVIORAL), Assigned Focus Area Feedback (BEHAVIORAL), Study Dashboard (Standard) (BEHAVIORAL), Study Dashboard (focused) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06101251?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06101251's enrollment target sits among peer trials
1,449 68th of 2000 higher than 1,933 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
- NCT05229341 · 1,450 participants · NA
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
- NCT05910268 · 1,450 participants · NA
Peru Decentralized HIV Care
- NCT06305312 · 1,450 participants · NA
Community Services Navigation to Advance Health Equity in Breast Cancer Screening
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI